TREVENA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-07-20: Reporting owner Habib Yacoub; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-05-20: Reporting owner Nunn Jason Raleigh; Form 4; Security Director Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-05-20: Reporting owner Yanni Barbara; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-05-20: Reporting owner Phillips Anne M.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-07-20 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $6.81 exercise price | 2015-07-21 | |
| 2015-05-20 | Nunn Jason Raleigh Director | 4 | Director Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | Yanni Barbara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | Phillips Anne M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | Nader Francois Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | MOULDER LEON O JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | McHugh Julie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | Koppel Adam Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-20 | DOUGHERTY MICHAEL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,870 8,870 owned after | $6.80 exercise price | 2015-05-21 | |
| 2015-05-04 | Bourdow Carrie L. Officer (SVP, Chief Commercial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $6.94 exercise price | 2015-05-05 | |
| 2015-03-17 | Limongelli John M Officer (Sr. VP,General Counsel & Secy) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $6.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $6.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Soergel David Officer (Sr. VP,Clinical Dev. & CMO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +87,500 87,500 owned after | $6.79 exercise price | 2015-03-19 | |
| 2015-03-17 | Lark Michael W. Officer (Sr. VP, Research & CSO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +87,500 87,500 owned after | $6.79 exercise price | 2015-03-19 | |
| 2015-03-17 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $6.79 exercise price | 2015-03-19 |